主要心脏骨髓瘤:流行病学,诊断和管理 - - 叙述性综述
Tommy Li1, Eric Nguyen1, Jamal Hasoon2
1Department of Anesthesiology Baylor College of Medicine.
Orthopedic reviews
|November 27, 2025
概括
初级心脏骨肉瘤是一种罕见的心脏癌症,它模仿其他心脏病,使得诊断变得困难. 由于它的稀有性,治疗是具有挑战性的,整体预后仍然很差.
科学领域:
- 心血管病理学心血管病理学
- 在瘤学瘤学.
- 罕见的癌症 罕见的癌症
背景情况:
- 主要心脏肉瘤很少见,骨肉瘤是最罕见的亚型之一.
- 据报道,原发性心脏骨髓瘤的病例不到60例.
- 由于模仿常见心脏病的非特异性临床表现,诊断具有挑战性.
研究的目的:
- 为了提供初级心脏骨髓瘤的概述.
- 讨论流行病学,临床表现和管理策略.
- 突出案例报告以了解变化和复杂性.
主要方法:
- 文学叙事审查. 文学叙事审查.
- 对流行病学数据的分析.
- 检查临床病例报告和管理策略.
主要成果:
- 临床表现往往模仿心力衰竭,心肌狭窄或冠状动脉疾病.
- 胸外回声心脏成像是主要的诊断成像方式.
- 手术切除是局部疾病的首选初始治疗方法.
结论:
- 由于心脏骨髓瘤的罕见性,很难建立初级心脏骨髓瘤的标准治疗指南.
- 目前的治疗包括手术,并可能使用化疗和放射治疗.
- 需要更好的理解和管理策略来改善整体预后不佳.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
743
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
743
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


